EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert
K-Number: K230169 · 2023-04-06
Device Summary
Frequently Asked Questions
What is the EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert?
EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert is a medical device that received FDA 510(k) clearance on 2023-04-06. The listed applicant is Encore Medical, L.P Dba Enovis. The 510(k) number is K230169.
When did EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert receive FDA 510(k) clearance?
EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert received FDA 510(k) clearance on 2023-04-06, under 510(k) number K230169.
Who is the listed applicant for EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert?
The FDA 510(k) record lists Encore Medical, L.P Dba Enovis as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert?
The FDA product code for EMPOWR Revision VVC+ (Varus / Valgus Constrained), e+ Tibial Insert is JWH.
Other records listing Encore Medical, L.P Dba Enovis as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: JWH)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.